PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2007
CASE
AUTH/1940/1/07 Bayer ⭐ Case of the Week

Bayer breach over Avelox leavepiece claim implying β€œfirst choice” for chest infections (AUTH/1940/1/07)

A GP challenged an Avelox leavepiece headline implying moxifloxacin should be the β€œfirst choice” for concerning chest infections. PMCPA ruled the claim…

2006
CASE
AUTH/1857/6/06 Roche Products

Roche: UK press release linked to US public website about Herceptin (AUTH/1857/6/06)

Complaint about alleged pre-licence promotion of Herceptin in early breast cancer. Most allegations not upheld, but Appeal Board found a breach where…

2006
CASE
AUTH/1855/6/06 Roche Products

AUTH/1855/6/06: Novartis v Roche β€” CellCept booklet and GI complications claims

Roche’s CellCept booklet on post-transplant GI complications was challenged by Novartis. Some pages were ruled misleading (data presentation and overall impression) and…

2007
CASE
AUTH/2043/8/07 Sanofi

Sanofi-Aventis: anonymous employee alleged off-label discussions about Plavix and competitor intelligence gathering (AUTH/2043/8/07)

Anonymous employee alleged they were asked to discuss off-label Plavix uses and gather intelligence on an unlaunched competitor. Panel was concerned about…

2017
CASE
AUTH/2998/12/17 Eli Lilly

AUTH/2998/12/17: Director v Lilly (Cyramza) – clinical trial disclosure

PMCPA case on clinical trial disclosure for Cyramza. Outcome: no breach and deemed outwith the scope of the ABPI Code (2016). No…

2015
CASE
AUTH/2766/5/15 Eisai ⭐ Case of the Week

Eisai: Clinical trial disclosure for Fycompa ruled outwith scope (AUTH/2766/5/15)

PMCPA Director considered a complaint about clinical trial disclosure for Fycompa. The matter was ruled outwith the scope of the ABPI Code,…

2018
CASE
AUTH/3015/1/18 Daiichi-Sankyo UK

AUTH/3015/1/18: Daiichi-Sankyo voluntary admissionβ€”medical signatories acted before MHRA/PMCPA notification

Daiichi-Sankyo admitted three medical staff certified 296 items before their names/qualifications were notified to MHRA and PMCPA. Panel found breaches of Clauses…

2006
CASE
AUTH/1850/6/06 Novartis Pharmaceuticals UK

AUTH/1850/6/06: Media/Director v Novartis β€” Disclosure of patient group involvement (No breach)

Financial Times alleged Novartis delayed disclosure of patient group funding. PMCPA ruled annual report disclosure timing was permitted under Clause 20.3. No…

2006
CASE
AUTH/1808/3/06 Wyeth

Wyeth: Sponsored nurses and GP audit service (GastroCare) – no breach (AUTH/1808/3/06, AUTH/1811/3/06)

Media and GP complaints alleged sponsored nurses were incentivised to influence prescribing via free GP audits. PMCPA found Wyeth’s GastroCare service was…

2007
CASE
AUTH/2029/7/07 Bristol-Myers Squibb ⭐ Case of the Week

Sanofi-Aventis & Bristol-Myers Squibb: MINAP meeting invitation misleadingly implied endorsement (AUTH/2029/7/07, AUTH/2030/7/07)

MINAP complained a sponsored meeting invite implied MINAP Steering Committee involvement/endorsement. Panel found the invitation misleading and not high standard (Clause 9.1),…

Roche Products

Roche & GSK Bonviva Once Monthly slide kits: NICE wording and β€˜class effect’ fracture efficacy implied

Two Bonviva slide kits were ruled misleading for implying NICE recommended ibandronate and for suggesting non‑vertebral efficacy/class effects. Breaches of Clauses 7.2…

2018
CASE
AUTH/3140/12/18 Amgen

Amgen: Incorrect Disclosure UK entries for a health professional with the same name (AUTH/3140/12/18)

A health professional said Disclosure UK wrongly showed Amgen support. Panel found no breach for 2015 (cause unclear) but breaches for 2016–2017…

2006
CASE
AUTH/1867/7/06 Roche Products

AUTH/1867/7/06: Anonymous employees v Roche β€” European meeting conduct and sales call-rate targets (No breach)

Anonymous Roche employees alleged misconduct at a European meeting and excessive call-rate targets. The Panel found no evidence of Code breaches and…

2008
CASE
AUTH/2099/2/08 Roche Products

Roche: Xenical supplied to private diet clinics and Β£55,000 clinic funding linked to prescribing (AUTH/2099/2/08 & AUTH/2100/2/08)

Roche was ruled in breach after Xenical was effectively supplied via a non-HCP at a private clinic and a proposed Β£55,000 clinic…

2010
CASE
AUTH/2354/9/10 Consilient Health ⭐ Case of the Week

AUTH/2354/9/10: Anonymous v Consilient Health β€” Promotion of oral contraceptives (out of scope; no breach)

PMCPA case AUTH/2354/9/10 (Anonymous v Consilient Health) about promotion of oral contraceptives. The matter was ruled outwith the scope of the ABPI…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training